That's a wrap.
Market opens Friday, Nov 13 at 9:30 AM ET
11:21 AMYahoo Finance
REGN soars 27.4% in a month: Buy, sell or hold the stock?
3:11 AMYahoo Finance
Regeneron Pharmaceuticals (REGN) reports early MASLD trial data with 62% liver fat normalization
1:17 PMYahoo Finance
Amgen vs. Regeneron: Higher dividends now or bigger growth later?
12:15 PMYahoo Finance
Regeneron Pharmaceuticals advances liver drug after early trial cuts liver fat by up to 80%
10:00 AMYahoo Finance
Alnylam Collaborator Regeneron advances CIDEBsiRNA with promising first-in-Human results in patients with MASLD
9:10 AMYahoo Finance
Regeneron Pharmaceuticals (REGN) extends BARDA deal as Libtayo long term data holds up
11:06 AMYahoo Finance
Mary Tyler Moore Vision Initiative Welcomes Regeneron and Adaptive Sensory Technology to its Consortium
5:36 AMYahoo Finance
Is Regeneron stock Riskier than it looks?
5:22 PMYahoo Finance
Is Regeneron stock increasing your market risk?
3:59 PMYahoo Finance
Was there any Sign Regeneron stock would run?
11:20 AMYahoo Finance
Why Regeneron (REGN) might be Well Poised for a surge
4:05 PMYahoo Finance
Regeneron announces investor Conference Presentations
2:33 PMYahoo Finance
REGN Q3 deep dive: pipeline progress and core brands drive outperformance
11:40 AMYahoo Finance
Regeneron's 'strong commercial' Q3 underscores core business health, RBC Capital markets says
9:00 AMYahoo Finance
Earnings roundup: AstraZeneca’s cost cuts, Alnylam’s slump and Regeneron’s resilience
8:49 AMYahoo Finance
The top 5 analyst questions from Regeneron’s Q3 earnings call
FDA Decision Watch: Regeneron and Roche’s Autoimmune Drugs, Capricor’s DMD therapy in spotlight